Fernando Rodríguez

Dr. Rodriguez received his PhD in Biology in 1994 and has dedicated his scientific career to exploring new methods to improve the safety and efficacy of vaccines. He completed his thesis at CISA-INIA (Madrid, Spain), working on the immunology of African swine fever thanks to a pre-doctoral fellowship from the Basque Government. In 1996, Dr. Rodriguez moved to The Scripps Institute (La Jolla, California, USA) to work as a research associate in Dr. Lindsay Whitton's laboratory, first with a postdoctoral fellowship from the Spanish government and then with one from the Basque government until 1999, when he was promoted to senior researcher. During these five years at The Scripps Institute, Dr. Rodriguez developed strategies to enhance CD4 and CD8 T-cell responses induced after vaccination using DNA immunization as a vaccine tool. In January 2001 he returned to Spain with a FIS contract from the Spanish Ministry of Health to work on cancer immunotherapy at the Hospital 12 de Octubre (Madrid). At the end of 2003, Dr. Rodriguez moved to CReSA (Barcelona, Spain) with a Ramon y Cajal contract, which was later extended with an I3 contract, and since then he has been the Senior Researcher of a research line dedicated to the study of African swine fever (ASF). In 2013, Dr. Rodriguez became the coordinator of the Exotic Diseases Program for CReSA and between 2018 and 2019 he acted as Scientific Director of CReSA, today becoming the Animal Health Program at IRTA (Barcelona, Spain).

Dr. Rodriguez has authored 82 international peer-reviewed scientific articles, 4 patents, and has coordinated 9 research projects and 5 private research contracts with national and international companies. Dr. Rodriguez has also supervised 9 doctoral theses.

Updated CV 12-Mar-2021